SCHEMBL11064374

SCHEMBL11064374

CC(=O)c1c[c]ccc1OCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
MAOB P27338 3/20 0.50
SGMS2 Q8NHU3 2/20 0.50
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
BRD4 O60885 1/20 0.48
GAA P10253 1/20 0.47
FOLH1 Q04609 1/20 0.46
NPC1 O15118 1/20 0.45
HTT P42858 1/20 0.45
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
RXRG P48443 1/20 0.44
CA9 Q16790 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5400533 0.86 SGMS2 (0.48) MAPTL3MBTL1SGMS2MEN1KMT2A
SCHEMBL9203023 0.84 HTT (0.53) SMN1; SMN2TDP1L3MBTL1SGMS2MEN1
SCHEMBL30468871 0.81 SGMS2 (0.67) MAPTCYP2C9CYP2C19SMN1; SMN2TDP1
SCHEMBL71081 0.81 SGMS2 (0.67) MAPTCYP2C9CYP2C19SMN1; SMN2TDP1
SCHEMBL1616224 0.78 MAPT (0.55) MAPTCYP2C9CYP2C19SMN1; SMN2TDP1
SCHEMBL183414 0.77 MAPT (0.48) MAPTCYP2C19SMN1; SMN2TDP1L3MBTL1
SCHEMBL3516973 0.77 LMNA (0.45) MAPTSMN1; SMN2L3MBTL1HTT
SCHEMBL6996715 0.76 APP (0.47) MAPTCYP2C9CYP2C19SMN1; SMN2TDP1
SCHEMBL9431930 0.76 L3MBTL1 (0.65) MAPTCYP2C9CYP2C19SMN1; SMN2TDP1
SCHEMBL8888358 0.75 LRRK2 (0.63) MAPTCYP2C9CYP2C19SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4425362-A CARDIOVASCULAR DISORDERS, ADRENERGIC BLOCKING AGENTS SANDOZ LTD. (CH) 1984-01-10 US disclosed